Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity
- 12 October 2015
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 57 (5), 1122-1129
- https://doi.org/10.3109/10428194.2015.1079315
Abstract
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity. . ???aop.label???. doi: 10.3109/10428194.2015.1079315Keywords
This publication has 25 references indexed in Scilit:
- Efficacy of Vinorelbine Plus Granulocyte Colony–Stimulation Factor for CD34+ Hematopoietic Progenitor Cell Mobilization in Patients with Multiple MyelomaTransplantation and Cellular Therapy, 2014
- Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial)Leukemia & Lymphoma, 2014
- Current Multiple Myeloma Treatment Strategies with Novel Agents: A European PerspectiveThe Oncologist, 2010
- International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)Leukemia, 2009
- Autologous Hematopoietic Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2009
- Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphomaBone Marrow Transplantation, 2009
- Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literatureBlood, 2008
- High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-AutogreffeJournal of Clinical Oncology, 2005
- High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMABlood, 2005
- Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effectiveBone Marrow Transplantation, 2003